Sky and Space Global’s Initial Satellite Customer Boost


Published 30-AUG-2016 16:27 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Sky and Space Global (ASX:SAS) has secured new commercial contracts to sell the company’s nano-satellite bandwidth to end user customers.

Adding to its existing customer base, SAS entered into a binding Letter of Intent with Sat-Space Africa Ltd. (SSA), which agreed to purchase all available communication bandwidth from its initial 3 diamonds nano-satellite demonstration platform.

Sat Space Africa has operations and infrastructure in 27 African countries and its support for SAS is seen to not only validate the commercial viability of SAS’s technology, but could open up a much broader customer base, including key new industry targets mining and transportation.

These targets would also be a source of potential early stage revenue, with estimated revenue of US$500,000 (AU$378,000) per annum for the 3-Diamonds demonstration nano-sateliites. Potential revenue could grow to US$2M per annum once SAS’s Equatorial constellation is fully operational.

It should be noted that the arrangement is still in its very early stages and anything can happen. Investors should approach any investment decision in SAS with caution and seek professional financial advice.

About the deal, SAS CEO Meir Moalem said, “Our 3 Diamonds demonstration nano-satellites are already securing commercial value. This is a results of hard work by our team and by our strategic customer Sat-Space Africa. Together we will strive to further increase our footprint, add customers and services and expand into new markets including Asia and Central America.”

SAS intends to launch an Equatorial constellation of 200 nano-satellites commencing mid-2018. The quantum of bandwidth created from the full constellation is expected to generate revenues circa $500 million per annum.

SAS and SSA are currently working together to negotiate the progression of the binding letter of intent into a full commercial contract.

“We consider Sky and Space Global a strategic partner and will keep working with them to secure more agreements in the narrow-band communications market,” said Sat Space Africa’s MD, Shimri Lotan.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free